Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Cancer Research UK)"
Count: 278
Selected: 0
NCT IDTitle
NCT00863733Study of DMXAA (Now Known as ASA404) in Solid Tumors
NCT06045910A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
NCT05944237HTL0039732 in Participants With Advanced Solid Tumours
NCT05786716DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations
NCT05770544DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers.
NCT05770102DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
NCT05770037DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers
NCT05768178DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
NCT05722886DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
NCT05272709TT-702 in Patients With Advanced Solid Tumours.
NCT05057013HMBD-001 in Advanced HER3 Positive Solid Tumours
NCT04908111A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
NCT04455815A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)
NCT03486730BT1718 in Patients With Advanced Solid Tumours.
NCT03371485AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer
NCT03096054A CR-UK Phase I Trial of LY3143921
NCT02933320BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
NCT02761915A Phase I Trial of Anti-GD2 T-cells (1RG-CART)
NCT02546921Phase I Study of MOv18 IgE
NCT02540928AMG 319 in HPV Positive and Negative HNSCC
NCT02043899A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma
NCT01805375A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
NCT01800071A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
NCT01791595A Phase I Trial of AZD3965 in Patients With Advanced Cancer
NCT01668550A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours
NCT01586624A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)
NCT01585701Phase I Study of AT13148, a Novel AGC Kinase Inhibitor
NCT01561911A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment
NCT01431664AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia
NCT01390571Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
NCT01324115NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors
NCT01233492Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
NCT01222221Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT01212887Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer
NCT01147991Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer
NCT01147029GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy
NCT01132599Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer
NCT01118611Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors
NCT01098344MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery
NCT00989105Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer
NCT00985868AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors
NCT00755885Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
NCT00664781Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
NCT00259844Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases Removed
NCT00749450Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer
NCT0010489717-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma
NCT00974792Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
NCT00967954Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
NCT00967889Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT00963092Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer